Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
about
Overcoming challenges of treating inflammatory bowel disease in pregnancy.A free terminal ileal perforation from active crohn disease in pregnancy: a diagnostic challengeGrowth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases.Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women.Maternal inflammatory bowel disease and hypospadias in male offspring: a population-based study in DenmarkSafety of anti-TNF therapy in inflammatory bowel disease during pregnancy.Use of Immunomodulators and Biologics Before, During, and After Pregnancy.Managing IBD Therapies in Pregnancy.Disease-related pregnancy concerns and reproductive planning in women with inflammatory bowel diseases.The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study.Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy.Mutations in fetal genes involved in innate immunity and host defense against microbes increase risk of preterm premature rupture of membranes (PPROM).Intraventricular Hemorrhage Due to Coagulopathy After Vitamin K Administration in a Preterm Infant With Maternal Crohn Disease.Whole exome sequencing reveals HSPA1L as a genetic risk factor for spontaneous preterm birthPreconception Care: In the Continuum of Women’s HealthcarePreconception Care: In the Continuum of Women’s Healthcare
P2860
Q30251775-E4C97602-392F-445A-9F4A-6399481AB5C2Q35208418-BF7A29BB-4749-4966-AAF5-799A66541A11Q35239145-A5A4FA3E-D484-4151-B18D-5400ABB92F05Q36239177-41447A09-4F4F-43AA-871D-B3F0FE599364Q37454480-06507ADF-E2C4-4078-91C8-1FD1992720CAQ38269243-C1F7031E-DF1F-4F41-AB45-5C4FF844D7B3Q38601306-9826447C-AE2A-485C-9678-D53706F49C14Q38970533-ACB05913-5D59-43C6-9594-A47597B4E27DQ39015162-FD3039BB-B5C4-4EB4-9CC5-033B704ECE5EQ39651355-8F228A5E-292A-478A-8424-60B71142ACBBQ39961386-6EEB31B7-8513-48D2-BA54-82BF958BB032Q40177173-722052FB-3056-4799-A91D-2356D23D0E9EQ41601749-4A4DBB7A-E0AD-4649-92FE-EAFF22425D2FQ45074046-F2CFA8F0-B719-4111-AB57-DC3B0A77EE68Q49478880-B5099779-96C2-4789-B2AE-FCE6C9BD6E1FQ58300985-2940D6CE-4308-44E3-B6E6-412EE41E06DBQ58865564-F51AC94F-F2FC-4EC7-A405-9F2AB6BF869AQ58865569-699CDC9F-1BD6-4FB6-9A0B-D1628E6DB818
P2860
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@en
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@nl
type
label
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@en
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@nl
prefLabel
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@en
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@nl
P2093
P2860
P356
P1476
Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
@en
P2093
A M Langer-Gould
D Strickland
G F Longstreth
M J Fassett
P2860
P2888
P304
P356
10.1038/JP.2014.41
P577
2014-03-20T00:00:00Z